Results 41 to 50 of about 785 (150)
Acrocyanosis: The Least Known Acrosyndrome Revisited With a Dermatologic Perspective. [PDF]
Dermatol Res PractBackground: Acrocyanosis is a functional peripheral vascular disorder, currently categorized under the canopy of acrosyndromes, i.e., a group of clinically similar and significantly overlapping vascular disorders involving the acral skin. The disorder might be primary or secondary, depending on the cause.
Demircioğlu D, Öztürk Durmaz E.
europepmc +2 more sources
Sneddon Syndrome: A Case Report Exploring the Current Challenges Faced with Diagnosis and Management
Case Reports in Neurology, 2019 Sneddon syndrome (SS) is a rare medium-vessel vasculopathy which characteristically presents with livedo racemosa (LR) and complications such as strokes.
Jonathan Cleaver +5 more
doaj +1 more source
COVID-19 and cutaneous manifestations: Two cases and a review of the literature
Emergency Care Journal, 2022 COVID-19 can affect multiple organs, including skin. A wide range of skin manifestations have been reported in literature. Six main phenotypes have been identified: i) urticarial rash, ii) confluent erythematous/maculopapular/morbilliform rash, iii ...
Davide Bastoni +5 more
doaj +1 more source
A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran
Pediatric Rheumatology Online Journal, 2023 Background Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disease caused by mutations in the ADA2 gene. DADA2 has a broad spectrum of clinical presentations.
Kosar Asna Ashari +11 more
doaj +1 more source
Frontiers in Medicine, 2022 Livedoid vasculopathy (LV) is a thrombo-occlusive vasculopathy that involves the dermal vessels. Clinically, it is characterized by the presence of painful purpuric ulcers on the lower extremities.
Mireia Seguí, Mar Llamas-Velasco
doaj +1 more source
Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
Biology, 2021 The increasingly frequent cutaneous manifestations of coronavirus disease (COVID-19) remain to pose a problem to clinicians. Herein, we aimed to describe the clinical and pathological findings of skin lesions in patients with COVID-19.
Carmen Rodriguez-Cerdeira +10 more
doaj +1 more source
Recent topics related to etiology and clinical manifestations of cutaneous arteritis
Frontiers in Medicine, 2022 Cutaneous polyarteritis nodosa (cPAN) was first reported by Lindberg in 1931. It has been recognized as a skin-limited vasculitis whose cutaneous histopathological features are indistinguishable from those of PAN.
Takaharu Ikeda
doaj +1 more source
Arthritis &Rheumatology, Volume 78, Issue 5, Page 1124-1133, May 2026.Objective Antiphospholipid syndrome (APS) is a thromboinflammatory disorder characterized by clinical and mechanistic heterogeneity that complicates early diagnosis and hinders targeted treatment. We aimed to identify distinct molecular endotypes among antiphospholipid antibody (aPL)–positive patients using whole‐blood transcriptomics.
Amala Ambati +13 more
wiley +1 more source
Lymphocytic thrombophilic arteritis: An enigma
Indian Journal of Dermatology, 2014 A 55-year-old woman presented with a 5-year history of livedo racemosa on her limbs. Histology showed vasculitis of medium-sized arteries with a circumferential, hyalinised, intraluminal fibrin ring.
Inchara Yeliur Kalegowda +3 more
doaj +1 more source
Journal of Ayurveda Case Reports, 2021 COVID-19 patients have cutaneous manifestations such as herpes zoster, urticaria, chilblains, purpura, livedo racemosa, chickenpox-like eruptions in very small percentage.
Shantala T. R. Priyadarshini +2 more
doaj +1 more source